6th SoCalBio Digital Health Conference

March 24, 2023 — Location: Luxe Sunset Boulevard Hotel

7:30 AM

Registration Opens

8:00 AM


8:30 AM

Introductions by SoCalBio

9:00 AM

Keynote by Jamey Edwards, COO, Startup Health

Emerging Digital Medicine Technologies Re-Shaping the Future of Healthcare

There is a range of technology types from virtual & augmented reality, smart phone apps, smart headbands and video games
that are helping to shape the future of digital therapeutics and deliver effective solutions that meet stakeholders’ needs.

Panel Discussion:

  • Richard J. Gannotta, Senior Lecturer of Health Administration / Co Director MS Health Law & Strategy, NYU Robert F. Wagner Graduate School of Public Service
  • Josh Sackman, Co-Founder & President, , AppliedVR
  • David Skibinski, CEO, Mellitus Health
  • Arati Desai Wagabaza, CEO, Orcana

10:30 AM

Addressing Unmet Needs in Mental Health and Addiction

The role of digital health in addressing mental and behavioral disorders has expanded significantly. What digital health products have broken ground in this space? How can they help patients?

Panel Discussion:

  • Crystal Adesanya, CEO,Kira Health
  • Morgan Hewet, CEO, Options MD
  • Alec McCauley, CEO, Thrive Health
  • Yuri Sudhakar, Pres./ CEO, Nudj

11:30 AM

Networking and Visiting Sponsors’ Displays

12:00 PM


1:00 PM

Digital Biomarkers in Personalized Healthcare

Digital biomarkers refer to data collected by means of digital devices that are portable, wearable, implantable, or digestible. Finding patterns in such data may point to the onset of disease conditions. As such, digital biomarkers create an exciting field in healthcare to improve patient care and clinical research. Explore how digital biomarkers promise progress in preventive care, disease management, and improving the patient’s experience


  • Karen Cross, MD PhD FRCSC, CEO & Co-Founder, MIMOSA Dx
  • Robert Hamilton, PhD, CSO, NovaSignal
  • Shane Shahrestani, PhD , President, StrokeDx

2:00 PM

AI and Machine Learning Re-Shaping Imaging

With 3-5% of all medical imaging interpretation in the US contains errors, shortage of imaging clinicians, and high rate of burnout experiences by clinicians, artificial intelligence and machine learning offer novel tools  to help address these problems, increase diagnostic capacity, and support imaging technicians in the  early detection of acute conditions such as intracranial hemorrhage, pulmonary embolism, and pneumothorax. Assessing these conditions fast and accurately makes a big difference in the treatment’s cost and the patient’s outcome.


  • Kaushal Solanki, PhD, Founder and CEO, Eyenuk
  • Torrey Smith, CEO, Endiatx
  • Demetri Teropoulos, PhD , Co Founder & CSO, VoxelCloud

3:00 PM

Digital Health Funding: Future outlook


  • Chris Bostick, PhD, VP, OCV Partners
  • Jay Goss, General Partner, Wavemaker Three-Sixty Health
  • Parisa Khosropour, PreScreen Chair, Tech Coast Angels

4:00 PM

Regulating Software as a Medic al Device

The growth of digital health including digital medicine is expected to continue for many years. How will regulators balance the need to support innovation, while ensuring that these medical devices remain safe and effective?


  • Shep Bentley, Principal Consultant, Bentley Biomedical Consulting, LLC
  • Bruce Quinn, MD, Principal, Bruce Quinn Associates LLC
  • Kwame Ulmar, Managing Partner, MedTech Impact Partners

5:30 PM

Concluding Reception

7:00 PM

Conference Adjourns